<DOC>
	<DOCNO>NCT02733835</DOCNO>
	<brief_summary>This study prospective cohort study aim evaluate improve VPIA remifentanil algorithm would benefit labour mother unable unwilling receive epidural analgesia</brief_summary>
	<brief_title>VPIA Remifentanil Labour Pain Reduce Maternal Desaturation Improve Analgesic Titration</brief_title>
	<detailed_description>This study trials new Vital signs-controlled patient-assisted intravenous analgesia ( VPIA ) regimen use purpose-built pump aim enhance efficacy , safety personalization remifentanil therapy labour woman . The system study parturient 's pattern analgesic use 15 minute epoch titrates demand dose basal infusion rate maintain plasma level remifentanil appropriate degree pain felt . The system incorporate vital sign ( pulse oximetry heart rate value ) algorithm would temporarily stop pump step dose accordingly predefined critical value reach .</detailed_description>
	<mesh_term>Labor Pain</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Patients choose use parenteral opioid pain relief inform consent Patients refuse labour epidural analgesia contraindication epidural analgesia ( eg . thrombocytopaenia , previous thoracolumbar spinal instrumentation ) Gestational age &gt; = 36 week Patients unable understand instruction give regard use patient control analgesia ( PCA ) unable self administer PCA boluses Patients difficulty communication due language difference Patients know hypersensitivity remifentanil component formulation fentanyl analogue Patients severe respiratory disease Patients history drug dependence recreational drug abuse Patients unmanaged foetal bradycardia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>